OBJECTIVE: The development of artificial pancreas (AP) technology for deployment in low-energy, embedded devices is contingent upon selecting an efficient control algorithm for regulating glucose in people with type 1 diabetes mellitus. In this paper, we aim to lower the energy consumption of the AP by reducing controller updates, that is, the number of times the decision-making algorithm is invoked to compute an appropriate insulin dose. METHODS: Physiological insights into glucose management are leveraged to design an event-triggered model predictive controller (MPC) that operates efficiently, without compromising patient safety. The proposed event-triggered MPC is deployed on a wearable platform. Its robustness to latent hypoglycemia, model mismatch, and meal misinformation is tested, with and without meal announcement, on the full version of the US-FDA accepted UVA/Padova metabolic simulator. RESULTS: The event-based controller remains on for 18 h of 41 h in closed loop with unannounced meals, while maintaining glucose in 70-180 mg/dL for 25 h, compared to 27 h for a standard MPC controller. With meal announcement, the time in 70-180 mg/dL is almost identical, with the controller operating a mere 25.88% of the time in comparison with a standard MPC. CONCLUSION: A novel control architecture for AP systems enables safe glycemic regulation with reduced processor computations. SIGNIFICANCE: Our proposed framework integrated seamlessly with a wide variety of popular MPC variants reported in AP research, customizes tradeoff between glycemic regulation and efficacy according to prior design specifications, and eliminates judicious prior selection of controller sampling times.
OBJECTIVE: The development of artificial pancreas (AP) technology for deployment in low-energy, embedded devices is contingent upon selecting an efficient control algorithm for regulating glucose in people with type 1 diabetes mellitus. In this paper, we aim to lower the energy consumption of the AP by reducing controller updates, that is, the number of times the decision-making algorithm is invoked to compute an appropriate insulin dose. METHODS: Physiological insights into glucose management are leveraged to design an event-triggered model predictive controller (MPC) that operates efficiently, without compromising patient safety. The proposed event-triggered MPC is deployed on a wearable platform. Its robustness to latent hypoglycemia, model mismatch, and meal misinformation is tested, with and without meal announcement, on the full version of the US-FDA accepted UVA/Padova metabolic simulator. RESULTS: The event-based controller remains on for 18 h of 41 h in closed loop with unannounced meals, while maintaining glucose in 70-180 mg/dL for 25 h, compared to 27 h for a standard MPC controller. With meal announcement, the time in 70-180 mg/dL is almost identical, with the controller operating a mere 25.88% of the time in comparison with a standard MPC. CONCLUSION: A novel control architecture for AP systems enables safe glycemic regulation with reduced processor computations. SIGNIFICANCE: Our proposed framework integrated seamlessly with a wide variety of popular MPC variants reported in AP research, customizes tradeoff between glycemic regulation and efficacy according to prior design specifications, and eliminates judicious prior selection of controller sampling times.
Authors: Trang T Ly; Anirban Roy; Benyamin Grosman; John Shin; Alex Campbell; Salman Monirabbasi; Bradley Liang; Rie von Eyben; Satya Shanmugham; Paula Clinton; Bruce A Buckingham Journal: Diabetes Care Date: 2015-06-06 Impact factor: 19.112
Authors: Marc Breton; Anne Farret; Daniela Bruttomesso; Stacey Anderson; Lalo Magni; Stephen Patek; Chiara Dalla Man; Jerome Place; Susan Demartini; Simone Del Favero; Chiara Toffanin; Colleen Hughes-Karvetski; Eyal Dassau; Howard Zisser; Francis J Doyle; Giuseppe De Nicolao; Angelo Avogaro; Claudio Cobelli; Eric Renard; Boris Kovatchev Journal: Diabetes Date: 2012-06-11 Impact factor: 9.461
Authors: S D Patek; L Magni; E Dassau; C Karvetski; C Toffanin; G De Nicolao; S Del Favero; M Breton; C Dalla Man; E Renard; H Zisser; F J Doyle; C Cobelli; B P Kovatchev Journal: IEEE Trans Biomed Eng Date: 2012-04-03 Impact factor: 4.538
Authors: Joon Bok Lee; Eyal Dassau; Ravi Gondhalekar; Dale E Seborg; Jordan E Pinsker; Francis J Doyle Journal: Ind Eng Chem Res Date: 2016-10-27 Impact factor: 3.720
Authors: Rebecca A Harvey; Eyal Dassau; Wendy C Bevier; Dale E Seborg; Lois Jovanovič; Francis J Doyle; Howard C Zisser Journal: Diabetes Technol Ther Date: 2014-01-28 Impact factor: 6.118
Authors: Eyal Dassau; Cesar C Palerm; Howard Zisser; Bruce A Buckingham; Lois Jovanovic; Francis J Doyle Journal: Diabetes Technol Ther Date: 2009-03 Impact factor: 6.118
Authors: Ankush Chakrabarty; Justin M Gregory; L Merkle Moore; Philip E Williams; Ben Farmer; Alan D Cherrington; Peter Lord; Brian Shelton; Don Cohen; Howard C Zisser; Francis J Doyle; Eyal Dassau Journal: J Process Control Date: 2019-02-23 Impact factor: 3.666
Authors: Jhon E Goez-Mora; María F Villa-Tamayo; Monica Vallejo; Pablo S Rivadeneira Journal: Front Endocrinol (Lausanne) Date: 2021-04-26 Impact factor: 5.555